A randomized, double-blind, placebo controlled study of the efficacy of lithium for the treatment of pediatric mania followed by an open label long-Term safety period, double-blind, placebo-controlled discontinuation phase, and open label restabilization period (COLT2)
This study was the second of two multiphase, multicenter trials that comprehensively examined lithium in the treatment of pediatric participants with bipolar I disorder
| Main Author: | |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Bethesda, MD
Eunice Kennedy Shriver National Institute of Child Health and Human Development
December 1, 2015, 2015
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This study was the second of two multiphase, multicenter trials that comprehensively examined lithium in the treatment of pediatric participants with bipolar I disorder |
|---|---|
| Item Description: | "BPCA Protocol NICHD-2005-07-2 (COLT2); clinical study report.". - Proprietary information in this document has been redacted |
| Physical Description: | 1 PDF file (288 pages) illustrations |